<DOC>
	<DOCNO>NCT00851448</DOCNO>
	<brief_summary>To test compliance , tolerance , safety get preliminary insight efficacy new oral nutritional supplement ( contain n-3 fatty acid , amino acid antioxidant ) design prevent delay cachexia anorexia lung cancer patient .</brief_summary>
	<brief_title>Safety , Tolerance Efficacy Oral Nutritional Supplement Lung Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Cachexia</mesh_term>
	<criteria>nonsmall cell lung cancer patient stage IIIb IV plan chemotherapy combine chemo/radiotherapy current body weight less 6 month ago abnormal CRF level BMI &gt; =20 kg/m2 &lt; =30kg/m2 significant oedema time screen randomisation concomitant inflammatory disease active infection include HIV AIDS liver failure chronic renal failure cardiac pacemaker chronic heart failure insulin treat diabetes mellitus medication impair sex hormone synthesis , secretion function acute chronic infection body weight loss &gt; 5 % last 6 month &gt; 10 % last 10 month fish oil supplementation within 3 month prior study entry take vitamin dos great recommend daily allowance life expectancy le 6 month opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>